Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Lung Transplantation Safe, Effective in Older Patients

By HospiMedica staff writers
Posted on 26 Mar 2008
A new study has found that lung transplantation may be safely undertaken with acceptable clinical outcomes in patients over 65 years of age.

Researchers at the University of California Los Angeles (UCLA, USA) school of medicine reviewed the records of lung transplant recipients from March 2000 to September 2006, and compared the outcomes in 50 patients aged 65 years and older with a another group of 50 patients younger than 65 years that were matched to the older cohort by means of propensity analysis. More...
The median waiting time for both groups was less than three months throughout the observation period, and decreased to 47 days after a new allocation system was implemented in May 2005. Older patients were likelier to receive single-lung transplants (76%) than were younger patients (16%), with the minority of older patients receiving double-lung transplantation for severe pulmonary hypertension or infectious lung diseases.

The researchers found that there were no intraoperative deaths and no notable differences in median duration of mechanical ventilation, intensive care unit stay, hospital stay, oxygenation parameters, or in-hospital morbidity between the groups. The occurrence of bronchiolitis obliterans syndrome (BOS) in the first post-transplantation year was about twice as high in older recipients as was in younger patients; however, the prevalence of BOS plateaued in older patients but continued to increase in younger patients. There was no statistically significant difference in the prevalence of BOS overall between patients older versus younger than 65. There was no significant difference in the in-hospital, 1-year, or 3-year survival between the groups, though there were more deaths during the 1-month to 1-year interval in the older group because of infections, probably due to immunosenescence of the older patients. The study was published in the February 2008 issue of The Journal of Thoracic and Cardiovascular Surgery.

"Lung transplantation can be performed safely and with comparable short-term and medium-term survival in selected patients older than 65 years,” concluded lead author Raja Mahidhara, M.D., and colleagues of the division of cardiothoracic surgery. "However, multidisciplinary consensus is needed to determine the ethical standards in offering lung transplantation to the elderly given the critically short supply of donor organs.”

Current consensus guidelines recommend an upper age limit of 65 years for single-lung transplantation and 60 years for double-lung transplantation.


Related Links:
University of California Los Angeles

Gold Member
Neonatal Heel Incision Device
Tenderfoot
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Medical-Grade Display
HL2316SHTB
Syringe Pump
SP50 Series
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Critical Care

view channel
Image Credit: Adobe Stock

New ECG Foundation Model Enables Broad Cardiac Diagnosis and Risk Prediction

Electrocardiograms are central to cardiovascular decision-making, but conventional artificial intelligence models are often trained for narrow tasks, such as detecting a single arrhythmia.... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.